source
- Wave Life Sciences reports early-stage data showing monthly dosing possible for RNA editing therapy in AATDWave Life Sciences announced an updated cut of data from its early-stage study of an RNA editing treatment aimed at alpha‑1 antitrypsin deficiency (AATD). The new data suggest the genetic therapy…
- Nourish secures $100M funding, valuation climbs to $1.75BNourish, a New York-based telehealth platform that connects patients with nutritionists, announced a fresh financing round. The round raised $100 million and lifted the company's valuation to abou…